￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Talazoparib plus tazetostat is safe, produces signs of clinical benefit in mCRPC

2026-02-01 22:25:32

Check Details
Price inquiry of ceritinib after medical insurance reimbursement 2025

2026-02-01 22:25:32

Check Details
Can Mirdametinib be used in combination with other drugs?

2026-02-01 22:25:32

Check Details
Bestivan extends time to quality adjustment in advanced renal cell carcinoma without symptoms or toxicity

2026-02-01 22:25:32

Check Details
What drug is dabrafenib? What is its mechanism of action

2026-02-01 22:25:32

Check Details
First-line osimertinib combined with chemotherapy can enhance OS of EGFR+ non-small cell lung cancer

2026-02-01 22:25:32

Check Details
What medication details should you pay attention to during treatment with Vimseltinib?

2026-02-01 22:25:32

Check Details
What should not be eaten with Eltrombopag/Eltrombopag? Diet taboos while taking medication

2026-02-01 22:25:32

Check Details
Once you start taking Atrasentan, can you stop taking it at will?

2026-02-01 22:25:32

Check Details
Analysis of the main targets and mechanism of action of Telisotuzumab

2026-02-01 22:25:32

Check Details
What type of targeted drug does tazerestat belong to? What are the core indications?

2026-02-01 22:25:32

Check Details
Risks and responses to disease rebound after discontinuation of ceritinib

2026-02-01 22:25:32

Check Details
Category
相关知识